注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Ginkgo Bioworks Holdings Inc致力于建立一个对细胞进行编程的平台。该公司的平台用于代表其客户对细胞进行编程。其细胞程序旨在实现产品的生物生产,例如治疗剂,关键食品成分和来自石油的化学品。该公司通过两个部门运营:Foundry和Biosecurity。Foundry部门包括根据与公司细胞编程平台相关的合作和许可协议提供的研发服务。其细胞编程平台包括两项资产:Foundry、生物实验室设施,通过在工作流、定制软件、机器人自动化和数据科学与分析方面的投资实现,该平台与公司的代码库、生物部件集合和用于细胞编程的生物数据数据库相结合。Biosecurity部门包括主要向公共卫生部门提供的新冠肺炎检测产品和服务。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Eli Baker | 46 | 2020 | President, CFO, Secretary & Director |
Laurence E. Paul | 57 | 2021 | Independent Director |
Scott M. Delman | 61 | 2021 | Independent Director |
Dennis A. Miller | 64 | 2021 | Independent Director |
Joshua A. Kazam | 44 | 2021 | Independent Director |
Harry Evans Sloan | 71 | 2020 | CEO & Chairman |
Timothy Leiweke | 63 | 2021 | Independent Director |
Isaac Lee | 50 | 2021 | Independent Director |
Shyam Sankar | 40 | 2015 | Independent Chairman of the Board |
Harry Evans Sloan | 74 | 2021 | Independent Director |
Mark A. McCamish | 71 | 2024 | Member of Biopharma Advisory Board |
Kathy Hopinkah Hannan | 62 | 2022 | Independent Director |
John M. Maraganore | 62 | 2024 | Member of Biopharma Advisory Board |
Paolo Martini | - | 2024 | Member of Biopharma Advisory Board |
Sriram Kosuri | - | 2024 | Director |
Christi L. Shaw | 57 | 2024 | Member of Biopharma Advisory Board |
Ross Fubini | 48 | 2024 | Independent Director |
Jeff Legos | - | 2024 | Member of Biopharma Advisory Board |
Norbert W. Bischofberger | 68 | 2024 | Member of Biopharma Advisory Board |
Myrtle S. Potter | 66 | 2024 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核